You are here: All Products  > BeiGene Doses First Patient in China Phase I PARP Trial

BeiGene Doses First Patient in China Phase I PARP Trial

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products